In a public consultation, the Inter-agency Expert Group on Sustainable Development Goals indicators (IAEG-SDG) proposed an Antimicrobial Resistance(AMR)-specific indicator. This is the first suggested AMR-specific indicator among potential changes to the metrics tracking progress on the United Nations’ SDGs. The World Health Organization-proposed indicator on AMR is among the potential changes to Goal 3 (Good Health and Wellbeing). This proposal would aim to “reduce the percentage of bloodstream infections due to selected antimicrobial resistant organisms”. Earlier this year, ReAct highlighted antibiotic resistance’s implications for the Sustainable Development Goals and supports this proposed SDG indicator.
This proposed indicator is timely and necessary for the success for the SDGs which aim to address global challenges. In May 2019, the UN Secretary General stated:
Antibiotic resistance is undoubtedly an inter-sectoral challenge. However, only taking into account the prevalence of drug-resistant pathogens misses equally important concerns over needed access to antibiotics.
Universal access to antibiotics can stop 445,000 deaths
Providing universal access to antibiotics could avert 445,000 deaths from community-acquired pneumonia in children younger than 5 years—this statistic is only for children with pneumonia. This statistic points to a significant contributor to the estimated 700,000 annual deaths related to drug-resistant infections.
ReAct has proposed adaption of indicators to capture access of antibiotics
To ensure that the SDGs monitor not just excess use of antibiotics, ReAct has proposed that existing indicators might be adapted to capture access to these life-saving drugs.
One approach might be to extend the tracking of care-seeking behavior for children with suspected pneumonia (one of the tracer conditions already tracked under SDG Indicator 3.8.1).
Under SDG Indicator 3.b.3, there already is monitoring of a basket of medicines, including four antibiotics on WHO’s Essential Medicines List. Strategically selecting the four antibiotics being tracked under this SDG Indicator could focus attention on availability and affordability of these medicines, but more would need to be done to assess their appropriate use. And it might be important to include a last resort antibiotic among these four in order to capture more fully the picture of antibiotic access.
Need to monitor and reporting of antibiotic use in animal sector
Use of antibiotics for animals accounted for around 80% of total global consumption in 2013. Critically important antibiotics for humans are also used in food-producing animals. Monitoring and reporting of antibiotic use in the animal sector would also be vital to ensure that global policymakers can anticipate the impact of AMR on the SDGs. However, there are no proposed indicators to capture this One Health dimension of the problem.
Adding a new indicator means another indicator will be deleted
In considering new proposed indicators, the IAEG-SDG seeks to keep the burden of reporting unchanged, so every addition of a new indicator may well result in the deletion of another. So, the AMR-specific indicator will be competing against a broad array of proposed and existing indicators for a place in the monitoring of the SDGs.
Submit comments to the Open Consultation on SDGs by 8 September
To ensure the issue of antimicrobial resistance does not remain neglected in the monitoring of the SDGs, civil society groups and other stakeholders can submit comments to the Open Consultation on Sustainable Development Goals Google Form by 8 September, 2019.
Civil society groups and other stakeholders – submit comments to:
More news and opinion
- Four key points from joint comments to One Health Global Leaders Group on AMR
- Why are children more vulnerable to AMR?
- Dr Yoel Lubell, Health Economist, on Thailand, AMR, UCH and cultural factors driving AMR
- UHC and AMR: The Thai Experience
- Why do effective antibiotics matter for quality of care and patient safety?
- New ReAct policy brief: Antimicrobial resistance and universal health coverage – What’s the deal?
- Three key takeaways from the ReAct Africa conference
- Diagnostics: Species identification
- AMR-specific indicator proposed for monitoring Sustainable Development Goals
- Five focus areas at the 2nd Ministerial Conference on AMR hosted by the Netherlands
- Safety concerns of fecal microbiota transplants
- Upcoming ReAct Africa Conference: universal health coverage and antimicrobial resistance in focus
- Mother Earth conference in Argentina – the environment in focus
- Diagnostics: What are we talking about?
- Connecting global to local civil-society-agenda on AMR at CSO convening in Geneva
- ReAct colleagues featured in WHO Bulletin as leading profiles in the work on reacting to antibiotic resistance
- RAN stakeholder at WHO IPC consultation – for standards and guidelines in African Union member states
- WHA conversation on Antibiotic Resistance as a Global Development Problem co-organized by ReAct
- 8 insights from ReAct Asia Pacific project on antibiotic stewardship in secondary level hospitals in India
- Open letter to UN Member States from former IACG members Anthony So and Otto Cars
- ReAct UHC Intervention at UNGA Multi-stakeholder Hearing for High-level Meeting on UHC
- ReAct Latin America honors Earth Day
- Medicines Patent Pool’s view on the role of licenses for antibiotics – World Intellectual Property Day
- Second time for Innovate4AMR competition!
- World Health Day 2019: Universal Health Coverage
- Diagnostics: Constraints for successful implementation
- Antibiotic Shortages: magnitude, causes and possible solutions: A new WHO meeting report
- Erry Setyawan, FAO, on Indonesian NAP: We need to work together to make it possible to manage AMR
- ReAct’s new 5-year strategic plan receives funding from Sida
- How infections spread and how to stop them
- Generating data for policy and practice